- Home
- AFCG vs NTRB Comparison
AFCG vs NTRB Comparison
Compare AFCG & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFCG
- NTRB
- Stock Information
- Founded
- AFCG 2020
- NTRB 2016
- Country
- AFCG United States
- NTRB United States
- Employees
- AFCG N/A
- NTRB N/A
- Industry
- AFCG Real Estate Investment Trusts
- NTRB Industrial Specialties
- Sector
- AFCG Real Estate
- NTRB Health Care
- Exchange
- AFCG Nasdaq
- NTRB Nasdaq
- Market Cap
- AFCG 92.9M
- NTRB 87.2M
- IPO Year
- AFCG 2021
- NTRB N/A
- Fundamental
- Price
- AFCG $3.80
- NTRB $8.50
- Analyst Decision
- AFCG Hold
- NTRB Buy
- Analyst Count
- AFCG 5
- NTRB 1
- Target Price
- AFCG $8.17
- NTRB $13.00
- AVG Volume (30 Days)
- AFCG 270.1K
- NTRB 33.4K
- Earning Date
- AFCG 11-12-2025
- NTRB 09-09-2025
- Dividend Yield
- AFCG 15.87%
- NTRB N/A
- EPS Growth
- AFCG N/A
- NTRB N/A
- EPS
- AFCG N/A
- NTRB N/A
- Revenue
- AFCG $8,721,514.00
- NTRB $2,578,059.00
- Revenue This Year
- AFCG N/A
- NTRB $560.75
- Revenue Next Year
- AFCG $13.92
- NTRB $588.39
- P/E Ratio
- AFCG N/A
- NTRB N/A
- Revenue Growth
- AFCG N/A
- NTRB 42.92
- 52 Week Low
- AFCG $3.44
- NTRB $2.98
- 52 Week High
- AFCG $10.50
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- AFCG 34.71
- NTRB 68.38
- Support Level
- AFCG $3.69
- NTRB $7.30
- Resistance Level
- AFCG $4.01
- NTRB $7.94
- Average True Range (ATR)
- AFCG 0.16
- NTRB 0.38
- MACD
- AFCG -0.05
- NTRB 0.11
- Stochastic Oscillator
- AFCG 5.36
- NTRB 100.00
About AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to cannabis operators in the U.S. Through the management team's deep network and related credit and cannabis expertise. The company originates, structures, and underwrites loans secured by quality real estate assets, license value, and cash flows.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.